Roberth Ebert News Today

Dr. Cohen honored for his extensive contributions to basic and translational liver disease research FAIRFIELD, N.J., Nov. 7, 2022 /PRNewswire/ -- ...

Share this article Share this article NEW YORK and PERTH, Australia, March 17, 2021 /PRNewswire/ -- PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced the appointment of Michael Rosenblatt, MD, to its Board of Directors. Dr. Rosenblatt is a Senior Partner at Flagship Pioneering, a leading-edge innovation organization that conceives, creates and develops first-in-...